UBS Group’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

UBS Group’s Portfolio MRNY Stock Details MRNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$15	–	10930
2025 Q4	$15	Sell	1 -207	-100%	-$3.31K	﹤0.01%	10368
2025 Q3	$3.67K	Buy	+208	New	+$4.31K	﹤0.01%	9026
2024 Q1	–	Sell	-16	Closed	-$3.77K	–	9774
2023 Q4	$3.77K	Buy	+16	New	+$3.17K	﹤0.01%	7931

Other funds holding MRNY

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

MCA

McGuire Capital Advisors Bethany, Oklahoma $156M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SIS

Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

GSEP

Golden State Equity Partners South Coast Metro, California $1.32B AUM 23.87% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group's MRNY Position: Q1 2026 in Review

UBS Group sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q1 2026, closing a stake of 1 share — an estimated $15 sold.

UBS Group first reported a position in MRNY in Q4 2023 and held it in 3 quarters. The position peaked at $3.77K in Q4 2023. 11 funds tracked by Wall St. Rank hold MRNY as of Q1 2026.

UBS Group reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q1 2026 after selling out during the quarter.
UBS Group sold 1 YieldMax MRNA Option Income Strategy ETF share in Q1 2026, an estimated $15.
UBS Group first reported a position in YieldMax MRNA Option Income Strategy ETF in Q4 2023 and held it in 3 quarters.
UBS Group's YieldMax MRNA Option Income Strategy ETF position peaked at $3.77K in Q4 2023.
11 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.